BeloorBayir BioTech Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BeloorBayir BioTech Ltd. - overview
Established
1981
Location
Bangalore, -, India
Primary Industry
Pharmaceuticals
About
BeloorBayir BioTech Ltd. is a pioneering company specializing in the production of natural extracts and ingredients for diverse sectors such as food, cosmetics, and pharmaceuticals, emphasizing sustainability and eco-friendly practices. Founded in 1981, BeloorBayir BioTech Ltd. operates in Bangalore, India, focusing on the extraction of natural ingredients.
The company has undergone no significant pivots since its inception. In March 2014, Rabo Equity Advisors invested INR 750 million in the company, which reflects its commitment to growth. The founder's background is not publicly detailed, indicating a focus on the company's operations rather than individual history. The company has participated in one known deal, with the latest funding round being a GROWTH round, raising a total of INR 750 million.
BeloorBayir BioTech Ltd. specializes in producing high-quality natural extracts, essential oils, and flavoring agents for the food and beverage, cosmetics, and pharmaceuticals industries. The company’s focus on sustainable sourcing and eco-friendly extraction methods meets the growing consumer demand for organic ingredients, serving clients across North America, Europe, and Asia with plant-based extracts that enhance sensory and functional properties of products. In the most recent fiscal year of 2020, BeloorBayir BioTech Ltd.
reported a revenue of INR 9,386,390. 60 and an EBITDA of INR 1,142,579. 60, indicating its operational performance within the competitive market. BeloorBayir BioTech Ltd.
is actively exploring opportunities for growth by designing new products that cater to emerging market demands. The company aims to expand its operations into additional regions, with goals to penetrate markets in Europe and Asia by 2025. The funding received from Rabo Equity Advisors in March 2014 is expected to be utilized for these initiatives, supporting the development of new products and market expansion efforts.
Current Investors
Rabo Equity Advisors
Primary Industry
Pharmaceuticals
Sub Industries
Drug Stores/Convenience Stores, Pharmaceutical Research & Development
Website
www.bayirextracts.com/beloor_bayir
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
BeloorBayir BioTech Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | BeloorBayir BioTech Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.